Filter
2552
Filtered Results: 2552
Text search:
drug
trial
Featured
Recommendations
235
New Publications
504
Language
Document type
No document type
1498
Guidelines
401
Studies & Reports
400
Manuals
104
Strategic & Response Plan
54
Fact sheets
39
Training Material
22
Situation Updates
11
Infographics
10
Brochures
6
Resource Platforms
6
App
1
Countries / Regions
India
149
Global
86
South Africa
68
Western and Central Europe
54
Kenya
47
Nigeria
39
Ethiopia
38
Uganda
34
Africa
32
Tanzania
29
Eastern Europe
29
Zambia
29
Liberia
29
Malawi
27
Nepal
26
Sierra Leone
26
Russia
25
Ukraine
24
Ghana
22
Latin America and the Carribbean
21
Zimbabwe
20
Rwanda
19
Asia
18
Philippines
17
Bangladesh
17
Myanmar / Burma
16
South–East Asia Region
15
Brazil
14
Namibia
13
East and Southern Africa
12
Colombia
11
Lesotho
11
Mozambique
11
Cambodia
10
Germany
10
West and Central Africa
10
South Sudan
9
Indonesia
9
USA
8
Middle East and North Africa
8
Congo, Democratic Republic of
7
Botswana
7
Eswatini/ Swaziland
7
Thailand
6
Syria
6
Tajikistan
5
Cameroon
5
Albania
5
Guinea
5
Eastern Europe and Central Asia
5
Laos
4
Senegal
4
Burkina Faso
4
Venezuela
4
Argentina
4
Vietnam
4
Papua New Guinea
4
Sudan
4
Georgia
4
China
3
Haiti
3
Paraguay
3
Spain
3
Lebanon
3
Yemen
3
Central African Republic
3
Angola
3
Pakistan
3
North Macedonia
2
Mexico
2
Benin
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Jordan
2
Jamaica
2
United Kingdom
2
Portugal
2
Belarus
2
Bolivia
2
Sri Lanka
2
Poland
2
Iraq
2
Turkey
1
Gambia
1
Kazakhstan
1
Singapore
1
Peru
1
Qatar
1
Bulgaria
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Norway
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Mali
1
Bhutan
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
702
Clinical Guidelines
334
Public Health
138
Women & Child Health
99
Key Resources
37
Pharmacy & Technologies
29
Capacity Building
19
Toolboxes
HIV
344
Mental Health
338
TB
302
COVID-19
162
NTDs
151
AMR
94
NCDs
78
Pharmacy
73
Ebola & Marburg
58
Rapid Response
34
Caregiver
32
Refugee
29
Disability
24
Planetary Health
24
Global Health Education
15
Conflict
14
Health Financing Toolbox
12
Polio
10
Social Ethics
7
Specific Hazards
6
Cholera
6
Natural Hazards
5
Zika
3
Nature, vol.513 (4 September 2014) 13-14
Soil-transmitted helminths (STH) affect 1.45 billion people worldwide, and high intensity infections are associated with anemia, undernutrition and impaired cognition, particularly among children. Mathematical models suggest it may be possible to interrupt the transmission of STH in a community by e...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
DOI: 10.5772/intechopen.102891Little progress has been made since the 1960s and 19. 70s to widen the therapeutic arsenal against Trypanosoma cruzi, the causative pathogen of Chagas disease, which remains a frustrating and perplexing infectious disease. This chapter focuses on the strategic and opera...
The protozoan parasite Trypanosoma cruzi causes Chagas disease, an important public health problem throughout Latin America. Current therapeutic options are characterised by limited efficacy, long treatment regimens and frequent toxic side-effects. Advances in this area have been compromised by gaps...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
The pharmacological treatment of heart failure has evolved over the last three decades since the demonstration of the effect of angiotensinconverting enzyme inhibitors on major cardiovascular events in patients with heart failure with reduced ejection fraction. Composite analysis of heart failure wi...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
Phillips and colleagues have shown that rifampicin combined with clarithromycin is non-inferior to RS8, and is safer. This much anticipated trial provides us with a high degree of confidence that an 8-week course of oral rifampicin and clarithromycin should now be the cornerstone of the treatment of...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie...
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
